C4 Therapeutics (CCCC) Receivables - Net (2019 - 2026)
C4 Therapeutics (CCCC) reported Receivables - Net of $1.33 million for Q2 2026, down 38.2% from $2.16 million a year earlier and down 53.7% from the prior quarter.
Powered by 
Analysis
C4 Therapeutics (CCCC) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, C4 Therapeutics posted Receivables - Net of $2.4 million, down 22.6% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of -11.7% (FY2020 to FY2025).
- By year, Receivables - Net came in at $3.1 million in FY2024 (-73.7%), $11.8 million in FY2023 (+701.0%), $1.47 million in FY2022 (-74.2%) and $5.72 million in FY2021 (+27.5%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables - Net since Q2 2024.
- Year over year, Receivables - Net has now declined in each of the last four quarters, with an average decline of 27.3% over the last seven quarters.
- The high point for year-over-year Receivables - Net in five years was Q4 2023 (growth of 701.0%); the low point was Q4 2022 (a decline of 74.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.88 million (Q1 2026), $2.4 million (Q4 2025) and $6.54 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,152.37 Bn | 1,120.96 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 628.86 Bn | 547.39 Bn | 17.26 Bn |
| 3 | AbbVie | 500.37 Bn | 473.48 Bn | 12.70 Bn |
| 4 | Merck | 374.01 Bn | 328.39 Bn | 12.21 Bn |
| 5 | Novartis Ag | 300.56 Bn | 264.55 Bn | 11.24 Bn |
| 6 | Astrazeneca | 263.92 Bn | 237.60 Bn | 12.86 Bn |
| 7 | Amgen | 238.37 Bn | 193.77 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.21 Bn | 166.40 Bn | 6.22 Bn |
| 9 | Pfizer | 171.20 Bn | 117.84 Bn | 10.94 Bn |
| 10 | C4 Therapeutics | 412.35 Mn | -517.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33 Mn |
| Mar 31, 2026 | 2.88 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 6.54 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 8.03 Mn |
| Dec 31, 2024 | 3.10 Mn |
| Sep 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 13.60 Mn |
| Dec 31, 2023 | 11.80 Mn |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 528,000.00 |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.71 Mn |
| Mar 31, 2022 | 1.77 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 4.85 Mn |
API Access
C4 Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=CCCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "CCCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=CCCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();